心脏手术后液体复苏使用高渗盐水(HERACLES):初步随机对照临床试验研究方案
这是一项前瞻性双盲随机对照临床试验方案,计划纳入96例择期心脏手术患者,术后入ICU后随机接受5 ml/kg理想体重高渗盐水(7.3% NaCl)或生理盐水(0.9% NaCl)60分钟内输注,主要评估ICU期间累积液体输入量,并随访90天。
要点
- 心脏手术后液体正平衡影响预后,高渗盐水在初步研究中显示可降低液体平衡和体重增加。
- 拟纳入96例择期心脏手术患者,随机分组接受7.3% NaCl或0.9% NaCl 5 ml/kg理想体重。
- 主要目标是评估ICU期间干预组与对照组的累积液体输入量。
核心结论
- 该初步研究旨在检验假设:心脏手术后使用高渗盐水进行液体复苏相比标准ICU治疗能减少总液体输入量和术后体重增加。
研究设计与样本
- 前瞻性双盲随机对照临床试验,计划招募96例因缺血性和/或瓣膜性心脏病接受择期心脏手术的患者。
- 术后入ICU后随机接受5 ml/kg理想体重高渗盐水(7.3% NaCl)或生理盐水(0.9% NaCl)60分钟内输注。
- 术前及术后至第6天采集血尿样本评估肾脏、心脏、炎症、酸碱和电解质参数。
- 输注前、中、后行肾脏超声评估肾血流,术前术后行生物电阻抗体成分分析测量总体水。
- 随访90天。
关键数值与推荐
- 干预组:5 ml/kg理想体重高渗盐水(7.3% NaCl)60分钟内输注。
- 对照组:生理盐水(0.9% NaCl)相同方案输注。
- 主要目标为评估ICU期间干预组与对照组的累积液体输入量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intraoperative and postoperative management of cardiac surgery patients is complex, involving the application of differential vasopressors and volume therapy. It has been shown that a positive fluid balance has a major impact on postoperative outcome. Today, the advantages and disadvantages of buffered crystalloid solutes are a topic of controversy, with no consensus being reached so far. The use of hypertonic saline (HS) has shown promising results with respect to lower total fluid balance and postoperative weight gain in critically ill patients in preliminary studies. However, collection of more data on HS in critically ill patients seems warranted. This preliminary study aims to investigate whether fluid resuscitation using HS in patients following cardiac surgery results in less total fluid volume being administered. METHODS: In a prospective double-blind randomised controlled clinical trial, we aim to recruit 96 patients undergoing elective cardiac surgery for ischaemic and/or valvular heart disease. After postoperative admission to the intensive care unit (ICU), patients will be randomly assigned to receive 5 ml/kg ideal body weight HS (7.3% NaCl) or normal saline (NS, 0.9% NaCl) infused within 60 min. Blood and urine samples will be collected preoperatively and postoperatively up to day 6 to assess changes in renal, cardiac, inflammatory, acid-base, and electrolyte parameters. Additionally, we will perform renal ultrasonography studies to assess renal blood flow before, during, and after infusion, and we will measure total body water using preoperative and postoperative body composition analysis (bioimpedance). Patients will be followed up for 90 days. DISCUSSION: The key objective of this study is to assess the cumulative amount of fluid administered in the intervention (HS) group versus control (NS) group during the ICU stay. In this preliminary, prospective, randomised controlled clinical trial we will test the hypothesis that use of HS results in less total fluids infused and less postoperative weight gain when compared to the standard of intensive care in cardiac surgery patients. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03280745 . Registered on 12 September 2017.
引用
- Pfortmueller CA, Messmer AS, Hess B, et al. Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial. Trials. 2019. PMID: 31200756. doi:10.1186/s13063-019-3420-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。